Lung Cancer and ASCO 2020

The Lung Cancer Channel on VJOncology is supported by Takeda.
This supporter has no influence over the production of the content.

Lung Cancer and Asco 2020

The Lung Cancer Channel on VJOncology is supported by Takeda.
This supporter has no influence over the production of the content.
3:04
NSCLC highlights at ASCO 2020
Riyaz Shah • 19 Jun 2020
1:42
Horizon scanning in lung cancer
Sanjay Popat • 11 Jun 2020
2:03
Thoughts on the RAMES study in mesothelioma
Sanjay Popat • 11 Jun 2020
4:38
Targeted therapy in NSCLC at ASCO 2020
Riyaz Shah • 19 Jun 2020
4:11
Mesothelioma data at ASCO 2020
Riyaz Shah • 19 Jun 2020
2:28
Perspectives on the CheckMate 9LA study
Sanjay Popat • 11 Jun 2020
2:24
DS-8201 + pembro in patients HER2+ breast and NSCLC
Sanjay Popat • 11 Jun 2020
6:00
Interpreting the ADAURA data
Sanjay Popat • 11 Jun 2020
2:48
JVDF: immune profiling and clinical outcomes in patients treated with ramucirumab and pembrolizumab
Roy Herbst • 26 May 2020
4:24
Reflections on the ADAURA study
Jared Weiss • 3 Jun 2020
1:42
ADAURA: the benefit of adjuvant osimertinib
Tony Greco • 9 Jun 2020
3:01
Virtual oncology meetings
Martin Reck • 26 May 2020
3:04
Irinotecan/cisplatin vs etoposide/cisplatin in resected high-grade neuroendocrine lung carcinoma
Hirotsugu Kenmotsu • 1 Jun 2020
2:06
CheckMate-743 study in mesothelioma
Dean Fennell • 26 May 2020
3:37
CANOPY-A: canakinumab for early stage NSCLC
David Spigel • 28 May 2020
2:52
Advances in mesothelioma treatment
Dean Fennell • 26 May 2020
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals